4.7 Article

Prebiotics from acorn and sago prevent high-fat-diet-induced insulin resistance via microbiome-gut-brain axis modulation

Journal

JOURNAL OF NUTRITIONAL BIOCHEMISTRY
Volume 67, Issue -, Pages 1-13

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jnutbio.2019.01.011

Keywords

Prebiotic; Polysaccharides; Fibers; Microbiome; Metabolites; Obesity; Diabetes

Funding

  1. Center for Diabetes, Obesity and Metabolism at the Wake Forest School of Medicine
  2. Kermit Glenn Phillips II Chair in Cardiovascular Medicine at the Wake Forest School of Medicine
  3. Claude D. Pepper Older Americans Center at the Wake Forest School of Medicine [P30AG12232]
  4. Clinical and Translational Science Center (Clinical Research Unit) at the Wake Forest School of Medicine [UL1TR001420]
  5. Department of Defense's Discovery Award [W81XWH-18-1-0118]
  6. Iran National Science Foundation, Iran [96001117]
  7. [R01AG18915]

Ask authors/readers for more resources

Role of gut microbiome in obesity and type 2 diabetes (T2D) became apparent from several independent studies indicating that gut microbiome modulators like prebiotics may improve microbiome perturbations (dysbiosis) to ameliorate metabolic derangements. We herein isolate water soluble, nondigestible polysaccharides from five plant-based foods (acorn, quinoa, sunflower, pumpkin seeds and sago) and assess their impact on human fecal microbiome and amelioration of high-fat-diet (HFD)-induced obesity/T2D in mice. During polysaccharide isolation, purification, biochemical and digestion resistance characterization, and fermentation pattern by human fecal microbiome, we select acorn- and sago-derived prebiotics (on the basis of relatively higher purity and yield and lower protein contamination) and examine their effects in comparison to inulin. Prebiotics treatments in human fecal microbiome culture system not only preserve microbial diversity but also appear to foster beneficial bacteria and short-chain fatty acids (SCFAs). Feeding of acorn- and sago-derived prebiotics ameliorates HFD-induced glucose intolerance and insulin resistance in mice, with effects comparatively superior to those seen in inulin-fed mice. Feeding of both of novel prebiotics as well as inulin increases SCFAs levels in the mouse gut. Interestingly, gut hyperpermeability and mucosal inflammatory markers were significantly reduced upon prebiotics feeding in HFD-fed mice. Hypothalamic energy signaling in terms of increased expression of pro-opiomelanocortin was also modulated by prebiotics administration. Results demonstrate that these (and/or such) novel prebiotics can ameliorate HFD-induced defects in glucose metabolism via positive modulation of gut-microbiome-brain axis and hence could be useful in preventing/treating diet-induced obesity/T2D. (C) 2019 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available